Department of Clinical Pathology, Federal State Budgetary Institution "Research Institute of Human Morphology", 3, Tsyurupy Str, Moscow, 117418, Russian Federation.
Department of Obstetrics, Gynecology and Perinatology, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2, Trubetskaya Str., Moscow, 119991, Russian Federation.
Adv Ther. 2020 Jun;37(6):2580-2603. doi: 10.1007/s12325-020-01363-5. Epub 2020 May 8.
This review focuses on pathogenesis of endometriosis, its possible biomarkers and role in endometriosis-associated ovarian cancer. We analyzed various databases to obtain new insights, theories, and biomarkers associated with endometriosis. There are several theories of endometriosis development and biomarker changes including atypical forms. A number of studies have attempted to establish specific, reliable biomarkers to help diagnose endometriosis and endometriosis-associated diseases on the basis of different pathogenetic pathways. Nevertheless, despite intensive research extending even to the molecular level, the origin, natural history, malignant transformation, and laboratory management of endometriosis and related diseases are not yet clearly defined. Therefore, early laboratory diagnoses of endometriosis, its atypical form, and endometriosis-associated ovarian tumors are important problems that require further study in the context of advanced therapeutic strategies to provide maximal health benefits to patients.
本篇综述聚焦于子宫内膜异位症的发病机制、可能的生物标志物及其在子宫内膜异位症相关卵巢癌中的作用。我们分析了多个数据库,以获得与子宫内膜异位症相关的新见解、理论和生物标志物。子宫内膜异位症的发展和生物标志物变化有几种理论,包括非典型形式。许多研究试图根据不同的发病途径建立特定的、可靠的生物标志物,以帮助诊断子宫内膜异位症和子宫内膜异位症相关疾病。然而,尽管研究深入,甚至延伸到分子水平,但子宫内膜异位症及其相关疾病的起源、自然史、恶性转化和实验室管理仍未明确界定。因此,早期实验室诊断子宫内膜异位症、其非典型形式和子宫内膜异位症相关的卵巢肿瘤是重要问题,需要在先进治疗策略的背景下进一步研究,以最大限度地为患者带来健康益处。